Abstract

The aim of this study was to investigate S. aureus carriage among children with sickle cell disease (SCD), including the prevalence, risk factors, and antibiotic resistance. The study was cross-sectional, and involved 120 children with SCD recruited at the Princess Marie Louise Children’s Hospital (PML) in Accra and 100 apparently healthy children from environs of the hospital. Nasal swab samples were collected from the study participants and cultured for bacteria. Confirmation of S. aureus and methicillin-resistant Staphylococcus aureus (MRSA) isolates were done using the tube coagulase test and mecA polymerase chain reaction, respectively. All the S. aureus isolates were tested against standard antimicrobial agents using the Kirby-Bauer method. A structured questionnaire was used to obtain the socio-demographic and clinical data of the study participants. Binary logistic regression was used to identify determinants of S. aureus and MRSA carriage among the study participants. The nasal carriage prevalence of S. aureus was 33.3% (n = 40) and 10% (n = 10) among the participants of the SCD and control groups, respectively. As regards MRSA nasal carriage prevalence, the respective values were 3.33% (n = 4) and 0.00% (n = 0). SCD was significantly associated with S. aureus colonization (p < 0.0001, OR = 4.045), but not MRSA colonization (p = 0.128). In the SCD group, the significant predictors of S. aureus carriage were increasing age (p = 0.003; OR = 1.275) and living in self-contained apartments (p = 0.033; OR = 3.632), whereas male gender (p = 0.018; OR = 0.344) and the practice of self-medication (p = 0.039; OR = 0.233) were protective of S. aureus carriage. In the control group, a history of hospitalization in the past year was a risk factor for the carriage of S. aureus (p = 0.048; OR = 14.333). Among the participants of the SCD and control groups, respectively, the resistance prevalence recorded by S. aureus against the various antibiotics investigated were penicillin (100% each), cotrimoxazole (27.5% vs. 20%), tetracycline (25% vs. 50%), rifampicin (82.5% vs. 50%), erythromycin (30% vs. 20%), clindamycin (32.5% vs. 50%), gentamicin (7.5% vs. 20%), cefoxitin (27.5% vs. 20%), linezolid (30% vs. 40%), and fusidic acid (95% vs. 80%). The proportion of S. aureus isolates that were multidrug resistant (MDR) was 92.5% (37/40) in the SCD group and 100% (10/10) in the control group.

Highlights

  • Staphylococcus aureus is one of the predominantly isolated Gram-positive bacteria in clinical specimens, causing infections such as pneumonia, septicaemia, endocarditis, osteomyelitis, and meningitis [1,2,3,4]

  • The clinical significance of S. aureus has been accentuated by the emergence and spread of methicillin-resistant strains, which are characteristically different from methicillin-sensitive strains

  • The majority of the participants were enrolled in school (86.7% in the sickle cell disease (SCD) group vs. 97% in the control group), resided in compound houses (69.2% in the SCD group vs. 61% in the control group), and often washed their hands with soap

Read more

Summary

Introduction

Staphylococcus aureus is one of the predominantly isolated Gram-positive bacteria in clinical specimens, causing infections such as pneumonia, septicaemia, endocarditis, osteomyelitis, and meningitis [1,2,3,4]. It is a commensal of various parts of the body, including the skin, perineum and pharynx, but preferentially colonizes the moist squamous epithelium of the anterior nares of the nose [5,6]. The proportion of isolation of MRSA among S. aureus infections has increased to as high as 70% [15,16,17,18,19]. Inpatient stays due to MRSA infections cost USD 14,000, relative to the financial burden for all other stays (USD 7600), with a two-fold increase in the length of hospitalization [21,22]

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call